2.93
price down icon1.35%   -0.04
pre-market  Pre-mercato:  2.90   -0.03   -1.02%
loading
Precedente Chiudi:
$2.97
Aprire:
$2.93
Volume 24 ore:
191.96K
Relative Volume:
0.14
Capitalizzazione di mercato:
$23.65M
Reddito:
-
Utile/perdita netta:
$-16.60M
Rapporto P/E:
-3.2921
EPS:
-0.89
Flusso di cassa netto:
$-23.48M
1 W Prestazione:
-6.09%
1M Prestazione:
-4.56%
6M Prestazione:
-63.62%
1 anno Prestazione:
-79.75%
Intervallo 1D:
Value
$2.86
$3.0096
Intervallo di 1 settimana:
Value
$2.78
$3.16
Portata 52W:
Value
$2.78
$29.40

Briacell Therapeutics Corp Stock (BCTX) Company Profile

Name
Nome
Briacell Therapeutics Corp
Name
Telefono
(604) 921-1810
Name
Indirizzo
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Name
Dipendente
12
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-28
Name
Ultimi documenti SEC
Name
BCTX's Discussions on Twitter

Confronta BCTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
BCTX
Briacell Therapeutics Corp
2.93 23.65M 0 -16.60M -23.48M -0.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.82 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
520.29 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
321.94 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.53 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
267.12 28.51B 3.81B -644.79M -669.77M -6.24

Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-02-14 Iniziato H.C. Wainwright Buy

Briacell Therapeutics Corp Borsa (BCTX) Ultime notizie

pulisher
Jun 18, 2025

BriaCell Reports Increased Losses in Latest Financials - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

(BCT) Advanced Trading Insights (BCT:CA) - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 13, 2025

Briacell Therapeutics Corp expected to post a loss of $1.76 a shareEarnings Preview - TradingView

Jun 13, 2025
pulisher
Jun 12, 2025

Learn to Evaluate (BCT) using the Charts (BCT:CA) - news.stocktradersdaily.com

Jun 12, 2025
pulisher
Jun 10, 2025

(BCT) Strategic Equity Report (BCT:CA) - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 07, 2025

(BCT) Investment Analysis and Advice (BCT:CA) - news.stocktradersdaily.com

Jun 07, 2025
pulisher
Jun 04, 2025

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26 - GlobeNewswire

Jun 04, 2025
pulisher
Jun 04, 2025

(BCT) Pivots Trading Plans and Risk Controls (BCT:CA) - news.stocktradersdaily.com

Jun 04, 2025
pulisher
Jun 04, 2025

Stocks In Play - Baystreet.ca

Jun 04, 2025
pulisher
Jun 04, 2025

Stocks in play: BriaCell Therapeutics Corp. - The Globe and Mail

Jun 04, 2025
pulisher
Jun 04, 2025

BriaCell Therapeutics Corp. - Baystreet.ca

Jun 04, 2025
pulisher
Jun 04, 2025

BriaCell Therapeutics Schedules Virtual Investor Presentations for June 2025 - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26 | BCTX Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 02, 2025

BriaCell’s Bria-IMT Shows Strong Survival & Benefit in Advanced Breast Cancer - Insider Monkey

Jun 02, 2025
pulisher
Jun 02, 2025

Stocks In Play: BriaCell Therapeutics Corp. By Baystreet.ca - Investing.com Canada

Jun 02, 2025
pulisher
Jun 02, 2025

Stocks In Play: BriaCell Therapeutics Corp. - Barchart.com

Jun 02, 2025
pulisher
Jun 02, 2025

BriaCell Reports Promising Survival Data in Metastatic Breast Cancer Studies - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

BriaCell (BCTX) Shares Clinical Advancements at ASCO Meeting | B - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

BriaCell (BCTX) Shares Clinical Advancements at ASCO Meeting | BCTX Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025 - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

Clinical Trial Success: BriaCell's Breast Cancer Treatment Outperforms FDA-Approved Therapies at ASCO 2025 - Stock Titan

Jun 02, 2025
pulisher
Jun 01, 2025

(BCT) Stock Market Analysis (BCT:CA) - news.stocktradersdaily.com

Jun 01, 2025
pulisher
May 30, 2025

(BCT) Market Dynamics and Trading Signals (BCT:CA) - news.stocktradersdaily.com

May 30, 2025
pulisher
May 29, 2025

BriaCell (BCTX): Advances in Cancer Treatment with Bria-OTS | BC - GuruFocus

May 29, 2025
pulisher
May 28, 2025

BriaCell Therapeutics (NASDAQ:BCTX) Stock Price Up 1.6% – Should You Buy? - Defense World

May 28, 2025
pulisher
May 27, 2025

When (BCT) Moves Investors should Listen (BCT:CA) - news.stocktradersdaily.com

May 27, 2025
pulisher
May 27, 2025

BriaCell Therapeutics Corp - Baystreet.ca

May 27, 2025
pulisher
May 27, 2025

Cardiol Therapeutics Inc. - Baystreet.ca

May 27, 2025
pulisher
May 27, 2025

BriaCell advances cancer treatment with Bria-OTS in clinical study By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

BriaCell Bria-OTS? Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

BriaCell advances cancer treatment with Bria-OTS in clinical study - Investing.com

May 27, 2025
pulisher
May 27, 2025

BriaCell Advances Bria-OTS in Cancer Immunotherapy with New Study Phase - TipRanks

May 27, 2025
pulisher
May 27, 2025

BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Dos - GuruFocus

May 27, 2025
pulisher
May 27, 2025

BriaCell (BCTX): Advances in Cancer Treatment with Bria-OTS | BCTX Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

BriaCell's Breast Cancer Immunotherapy Shows Early Success: Patient's Lung Metastasis Completely Resolved - Stock Titan

May 27, 2025
pulisher
May 24, 2025

(BCT) Advanced Equity Analysis (BCT:CA) - news.stocktradersdaily.com

May 24, 2025
pulisher
May 23, 2025

BriaCell Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (BCT) - The Globe and Mail

May 23, 2025
pulisher
May 23, 2025

BriaCell (BCTX) Showcases Promising Data at ASCO 2025 | BCTX Sto - GuruFocus

May 23, 2025
pulisher
May 23, 2025

BriaCell Therapeutics Reports Promising Phase 2 Results for Metastatic Breast Cancer Treatment - TipRanks

May 23, 2025
pulisher
May 23, 2025

BriaCell to Showcase Survival and Clinical Benefit Data at ASCO Meeting Next Week - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

BriaCell (BCTX) Showcases Promising Data at ASCO 2025 | BCTX Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025 - The Manila Times

May 23, 2025
pulisher
May 23, 2025

‘Don’t Doubt UNH Yet,’ Top JPMorgan Analyst Defends UnitedHealth Stock amid Recent Volatility - The Globe and Mail

May 23, 2025
pulisher
May 23, 2025

Breakthrough: BriaCell's New Breast Cancer Drug Shows 13.4-Month Survival Rate, Beating Standard Therapies - Stock Titan

May 23, 2025
pulisher
May 23, 2025

OpenAI CEO Sam Altman Admits Even They Are ‘a Little Bit Scared’ of What They’re Building—But That’s a Good Thing - The Globe and Mail

May 23, 2025
pulisher
May 23, 2025

Stock Market News Today, 5/22/25 – Futures Flat, Post Deficit-Fear-Driven Sell-Off - The Globe and Mail

May 23, 2025
pulisher
May 22, 2025

Moderna Stock Looks Ripe for a Short Squeeze - The Globe and Mail

May 22, 2025
pulisher
May 22, 2025

(BCT) Trading Signals (BCT:CA) - news.stocktradersdaily.com

May 22, 2025
pulisher
May 20, 2025

BriaCell CEO Letter to Shareholders | BCTX Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

BriaCell (BCTX) Reports Promising Advances in Cancer Treatment Studies | BCTX Stock News - GuruFocus

May 20, 2025

Briacell Therapeutics Corp Azioni (BCTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.52
price down icon 1.06%
$35.91
price down icon 0.64%
$21.27
price up icon 1.67%
$104.85
price down icon 0.99%
$104.80
price down icon 0.28%
biotechnology ONC
$267.12
price up icon 0.12%
Capitalizzazione:     |  Volume (24 ore):